Dr Anand Shah

Sub-specialties: Respiratory Medicine, Bronchiectasis, Acute and chronic cough, Breathlessness, Lung Health.

02036532006

Overview

Dr Anand Shah is a Consultant in Respiratory medicine here at OneWelbeck Lung Health, and at the Royal Brompton hospital with expertise across all areas of respiratory medicine and a particular specialist interest in lung infection, fungal lung disease and bronchiectasis

About Dr Anand Shah

Dr Anand Shah works in the host defence unit at the Royal Brompton hospital which is one of the largest bronchiectasis, non-tuberculous mycobacteria and fungal disease units in the world and also as a clinical lecturer at Imperial College London.

Dr Shah is actively involved in research within respiratory disease and has received a number of prestigious research awards and grants with ongoing active pioneering research and clinical trials particularly in the field of COVID-19, bronchiectasis and fungal lung disease. He has authored over 50 papers is an editor at a number of internationally renowned journals and chairs a number of international clinical research consortiums. He was also a member of the British Thoracic Society Strategic advisory group on respiratory infection (2018-2022) and specialist advisory group to the NICE COVID-19 rapid guideline committee.

Areas of Expertise

Dr Anand Shah's area of expertise include:

Respiratory infection including COVID-19
Bronchiectasis
Fungal lung disease and allergy
Non-tuberculous mycobacteria
Breathlessness
Acute and chronic cough
General Respiratory Medicine

Additional Information

Clinical Posts:

Consultant Respiratory Medicine at the Royal Brompton Hospital, Guy's and St. Thomas' NHS Foundation Trust

Memberships:

Fellow of the Royal College of Physicians
British Thoracic Society
European Respiratory Society

Awards:

MRC Clinical Academic Research Partnership award - 2019
CF Trust Venture Innovation award - 2019
Vertex Research Innovation award - 2018
Gilead Invasive Fungal Infection fellowship award - 2018
CF Trust Clinical Excellance and Innovation award - 2017
Darzi Fellowship in Clinical Leadership (Sponsor) - 2017 and 2018
MRC Clinical PhD Research Fellowship - 2012

Research Highlights

1. A persistent neutrophil-associated immune signature characterises post-COVID-19 pulmonary sequelae

George P, Reed A, Desai S, Devaraj A, Faiez T, Laverty S, Liu M, Kamal F, Man W, Kaul S, Singh S, Lamb G, Burgoyne T, Pinto A, Farne H, Dalla Priya A, Aswani A, Patella F, Borek W, Dokal A, Xu X, Kelleher P, Shah A*, Singanayagam A. *co-senior author Science Translational Medicine 2022 Nov 16;14(671)

2. Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness.

Cutherbertson L, Turner S, Jackson A, Ranson C, Loosemore M, Kelleher P, Moffatt M, Cookson W, Hull J, Shah A. EBioMedicine 2022 May Vol 79

3. Impaired Humoral and Cellular Responses to SARS-CoV-2 Vaccine in Heart and Lung Transplant Recipients

Gerovasili V, Shah A, Singanayagam A, George P, Njafuh R, Prendecki M, Carby M, Willicombe M, Kelleher P, Reed A. American Journal of Respiratory and Critical Care Medicine. 2022 Mar 25. doi: 10.1164/rccm.202109-2026LE.

4. Calcineurin orchestrates lateral transfer of Aspergillus Fumigatus during macrophage cell death.

Shah A, Kannambath S, Herbst S, Rogers A, Carby C, Reed A, Mostowy S, Fisher M, Shaunak S, Armstrong-James D. American Journal of Critical Care and Respiratory Medicine, 2016 Nov 1;194(9):1127-1139

5. A longitudinal study of an adult primary ciliary dyskinesia cohort.

Shah A, Shoemark A, McNeill S, Rogers A, Bilton D, Hansel D, Wilson R, Loebinger M European Respiratory Journal 2016 Aug;48(2):441-50

Reviews

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.